📰 Biocon Ltd News
Page 2 - Biocon Ltd News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Biocon Ltd. Real-time updates on events, politics, business and more.
May 23, 2024
The Nifty Pharma index closed 0.52 per cent down at 19216.35.
May 21, 2024
The US Food and Drug Administration (USFDA) has approved the companys first-to-file application for Yesafili, a vascular endothelial growth factor inhibitor used to treat several different types of ophthalmology conditions, the company said in a statement.
May 21, 2024
The Nifty Pharma index was trading 0.11 per cent down at 19086.2.
May 21, 2024
Biocon Biologics secures FDA approval for Yesafili, an interchangeable biosimilar to Eylea, for ophthalmological conditions. Launch in Canada set.
May 21, 2024
This open high low scanner or OHL Scanner uses the popular open high low same trading strategy to find profitable stocks from NSE.
May 21, 2024
(RTTNews) - Biocon Biologics, a subsidiary of Biocon Ltd, announced the FDA has approved the companys first-to-file application for Yesafili, an ...
May 17, 2024
The Nifty Pharma index was trading 0.05 per cent up at 19004.75.
May 16, 2024
An analyst from YES Securities said Infosys has displayed a bearish sentiment evidenced by its breakdown from the rising channel pattern observed on the weekly chart.
May 16, 2024
The Nifty Pharma index was trading 0.03 per cent up at 18891.6.
May 16, 2024
The global type 1 diabetes market size is calculated at USD 15.95 billion in 2024 and is expected to be worth around USD 24.36 billion by 2031, growing at...